Search

everythinglearnresearchcommunity

for

Search:↓

Vaccination is crucial for psoriasis patients on immunosuppressive therapy to manage COVID-19 risks.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Minoxidil may help hair growth by stopping immune system attacks on hair follicles.

Restoring nerve-macrophage communication may help treat autoimmune diseases.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

A lotion with 5% minoxidil boosts the immune response in guinea pigs.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

JAK inhibitors may reverse early hair loss, but prolonged inflammation can cause permanent hair loss.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

IL-1 and IL-7 help activate cells that boost hair follicle stem cell growth, aiding wound healing.

Topical Imiquimod may fight vascular tumors by affecting blood vessels or the immune system, low iron might be linked to some hair loss, removing the top skin layer helps vitamin C get in, genetic testing helps diagnose skin conditions, and too much iron could worsen skin inflammation.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.